Fulgent Genetics Inc (FLGT)
Solvency ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.09 | 1.08 | 1.08 | 1.09 | 1.09 | 1.10 | 1.12 | 1.12 | 1.10 | 1.16 | 1.15 | 1.25 | 1.23 | 1.32 | 1.10 | 1.10 | 1.07 | 1.12 | 1.10 | 1.11 |
Fulgent Genetics Inc's solvency ratios indicate a consistently low level of debt relative to its assets, capital, and equity over the past eight quarters. The debt-to-assets ratio has been stable at 0.00 or 0.01, illustrating that the company has minimal debt in relation to its total assets. Similarly, the debt-to-capital and debt-to-equity ratios have also remained at low levels of 0.00 to 0.02 across the same period, highlighting strong financial health and a low reliance on debt financing.
The financial leverage ratio, which indicates the company's ability to meet its financial obligations through its borrowed funds, has fluctuated slightly but generally remained between 1.08 and 1.12. This implies that Fulgent Genetics has modest leverage and is capable of meeting its debt obligations comfortably.
Overall, based on the solvency ratios analyzed, Fulgent Genetics Inc appears to have a solid financial position with minimal debt levels and the capacity to manage its financial commitments effectively.
Coverage ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | -2,230.44 | -121.47 | -108.56 | -71.46 | 538.83 | 1,739.30 | 3,828.47 | 5,277.54 | 5,831.42 | 6,996.83 | 8,419.55 | 11,347.29 | 1,099.12 | 125.64 | 3.89 | -1.06 | -1.72 | — | — | — |
The lack of data for interest coverage in the table provided prevents a direct calculation or analysis of Fulgent Genetics Inc's ability to cover its interest expenses with its operating income. Interest coverage is a critical financial metric that indicates a company's ability to meet its interest obligations from its operating earnings. Without the specific figures for interest coverage across the mentioned quarters, a detailed analysis or trend assessment of Fulgent Genetics Inc's ability to service its interest payments cannot be performed. It is essential to have this information to evaluate the company's financial health and assess its ability to manage debt effectively.